DC11064 |
BTK PROTAC 9 |
BTK PROTAC 9 is a novel potent PROTAC for BTK with DC50 of 5.9 nM in cultured Ramos cells, requires simultaneous engagement of BTK and CRBN to effectively degrade BTK. |
|
DC11588 |
CC-885
Featured
|
CC-885 (CC 885, CC885) is a novel E3 ligase cereblon (CRBN) modulator with potent anti-tumour activity mediated through the degradation of GSPT1. |
|
DC11679 |
CCT-367766
Featured
|
CCT367766 is a potent and the third generation heterobifunctional and PROTAC-based pirin targeting protein degradation probe (PDP), depletes pirin protein expression at low concentration. CCT367766 exhibits a moderate affinity for the CRBN-DDB1 complex with an IC50 value of 490 nM. CCT367766 reveals a good affinity for the recombinant pirin and CRBN with Kd values of 55 nM and 120 nM, respectively. CCT367766 provides a potential chemical tool to study a largely unexplored protein[1]. |
|
DC12023 |
dBET1
Featured
|
dBET1 is a potent BRD4 protein degrader based on PROTAC technology with an EC50 of 430 nM. |
|
DC21893 |
dBET57
Featured
|
dBET57 is a novel BRD4 heterobifunctional small-molecule ligand (PROTAC), exhibits significant and selective degradation of BRD4 BD1 (DC50/5h=500 nM), but is inactive on BRD4 BD2.. |
|
DC12022 |
dBET6
Featured
|
dBET6 is a highly potent, selective and cell-permeable degrader of BET with an IC50 of 14 nM, and has antitumor activity. |
|
DC11589 |
dBRD9
Featured
|
dBRD9 is a PROTAC that bridge the BRD9 bromodomain and the cereblon E3 ubiquitin ligase complex. |
|
DC20367 |
dTRIM24
Featured
|
dTRIM24 is a potent TRIM24 bromodomain inhibitor with IC50 of 217.8 nM (TRIM24 ligand displacement). |
|
DC11570 |
E3 Ligand-Linker Conjugate 5 |
E3 Ligand-Linker Conjugate 5 is an E3 ligase ligand-linker conjugate for PROTAC.. |
|
DC12249 |
E3 ligase Ligand 1 dihydrochloride |
E3 ligase Ligand 1 dihydrochloride is a Hippel-Landau (VHL) E3 ligase-binding moiety based on PROTAC technology. |
|
DC22335 |
E3 ligase Ligand 1A
Featured
|
E3 ligase Ligand 1A is a ligand of E3 ligase, used in PROTAC technology; E3 ligase Ligand 1A can be used in the research of cancer.
(S,R,S)-AHPC-Me (VHL ligand 2) is the (S,R,S)-AHPC-based VHL ligand used in the recruitment of the von Hippel-Lindau (VHL) |
|
DC11565 |
E3 Ligase Ligand 2
Featured
|
E3 ligase Ligand 2 is a Ligand for E3 Ligase used in PROTAC technology. |
|
DC11571 |
E3 Ligase Ligand 3
Featured
|
E3 ligase Ligand 3 is a ligand of E3 ligase, used in PROTAC technology. |
|
DC12141 |
E3 Ligase Ligand-Linker Conjugates 22
Featured
|
E3 Ligase Ligand-Linker Conjugates 22 incorporates an E3 ligase ligand and a linker, can be used for the treatment of EZH2-mediated cancer. |
|
DC12092 |
E3 Ligase Ligand-Linker Conjugates 23 TFA |
E3 Ligase Ligand-Linker Conjugates 23 (TFA) is a synthesized compound that incorporates an E3 ligase ligand and a linker used in PROTAC technology. |
|
DC12181 |
E3 Ligase Ligand-Linker Conjugates 25 Trifluoroacetate |
E3 Ligase Ligand-Linker Conjugates 25 Trifluoroacetate is a synthesized compound that incorporates an E3 ligase ligand and a linker used in PROTAC technology. |
|
DC10932 |
HDAC6 degrader 9c |
HDAC6 degrader 9c (dHDAC6 9c) is a bifunctional molecule (dHDAC6) that could selectively degrade HDAC6, by conjugating non-selective HDAC inhibitor to a thalidomide-type E3 ligase ligand. |
|
DC12028 |
MDK7526(Protein degrader 1)
Featured
|
MDK7526, also known as VHL Ligand 1; Protein degrader 1, is a potent and selective protein degrader. |
|
DC21351 |
MS4078
Featured
|
MS4078 is a novel PROTAC (degrader) of ALK, potently decreases cellular levels of oncogenic active ALK fusion proteins in a concentration- and time-dependent manner in SU-DHL-1 lymphoma and NCI-H2228 lung cancer cells (DC50=11 nM). |
|
DC21360 |
MZ1
Featured
|
MZ1 is a PROTAC that tethers JQ1 to a ligand for the E3 ubiquitin ligase VHL, triggers, induces degradation of the BET bromodomain BRD4. |
|
DC20512 |
VHL ligand 1
Featured
|
PROTAC-VHL-ligand is a von Hippel–Lindau (VHL) ligand used for the proteolysis targeting chimeras (PROTACs) method, induces target protein degradation.. |
|
DC11040 |
QCA570 |
QCA570 is a novel, highly potent efficacious BET degrader (PROTAC). |
|
DC11816 |
RapaLink-1
Featured
|
RapaLink-1 is a third-generation mTOR inhibitor that overcomes resistance to existing first- and second-generation inhibitors; blocks mTOR signaling of the F2108L mTOR and M2327I mTOR drug resistant mutants; RapaLink-1 is more potent mTOR inhibitor than rapamycin. |
|
DC11584 |
SNIPER(ABL)-062 |
SNIPER(ABL)-062 is a novel, potent SNIPER molecule that tethers BCR-ABL inhibitor to a ligand of IAP, causes potent BCR-ABL degradation. |
|
DC11749 |
THAL-SNS-032
Featured
|
THAL-SNS-032 is a novel CDK9 degrader PROTAC consisting of a CDK-binding SNS-032 ligand linked to a thalidomide derivative that binds the E3 ubiquitin ligase Cereblon (CRBN). |
|
DC11579 |
VH032
Featured
|
VH-032 (VHL ligand 1) is a VHL ligand for PROTAC and potent, small molecule inhibitor of the VHL/HIF-1α interaction with Kd of 185 nM.. |
|
DC26119 |
VHL ligand 2 hydrochloride
Featured
|
VHL ligand 2 hydrochloride) is the (S,R,S)-AHPC-based VHL ligand used in the recruitment of the von Hippel-Lindau (VHL) protein. (S,R,S)-AHPC-Me hydrochloride can be used to synthesize ARV-771, a von Hippel-Landau (VHL) E3 ligase-based BET PROTAC degrader. |
|
DC11002 |
NTN21277(Gefitinib-based PROTAC 3)
Featured
|
Gefitinib-based PROTAC 3, conjugating an EGFR binding element to a VHL ligand via a linker, induces EGFR degradation with DC50s of 11.7 nM and 22.3 nM in HCC827(exon 19 del) and H3255 (L858R mutantion) cells, respectively. |
|
DC11001 |
Foretinib-Based PROTAC 7 |
|
|
DC22337 |
E3 ligase Ligand 4(TC-E3 5032)
Featured
|
E3 ligase Ligand 4 is a ligand of E3 ligase, used in PROTAC technology. |
|